C12Y 301/2701
Rrna endonuclease
Official title: rRNA endonuclease (3.1.27.10)
C12Y301/2701 (Rrna endonuclease) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 3
- Assignees
- 2
- Inventors
- 6
- Latest grant
- 13 Oct 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
By publication year.
Recent patents
- Pharmaceutical composition for preventing or treating LDL cholesterol-related diseases, containing ribosome-binding preparation13 Oct 2020US 10,799,477 B2Pusan National University Industry-University Cooperation Foundation
- Ribotoxin molecules derived from sarcin and other related fungal ribotoxins22 May 2018US 9,976,131 B2Research Corporation Technologies, Inc.
- Ribotoxin molecules derived from sarcin and other related fungal ribotoxins28 Mar 2017US 9,603,911 B2Research Corporation Technologies, Inc.
- Pharmaceutical composition for preventing or treating ldl cholesterol-related diseases, containing ribosome-binding preparation20 Jun 2019US 2019/0183858 A1Pusan National University Industry-University Cooperation Foundation
- Ribotoxin molecules derived from sarcin and other related fungal ribotoxins20 Jul 2017US 2017/0204387 A1Research Corporation Technologies, Inc.
- Ribotoxin molecules derived from sarcin and other related fungal ribotoxins21 Apr 2016US 2016/0106819 A1Research Corporation Technologies, Inc.
Most cited
By later US patents